|



Key: Meeting
Journal
Funder

Showing releases 2976-3000 out of 3325. << < 115 | 116 | 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 > >>

Public Release: 2-Jul-2012
 Cancer Research
Single protein promotes resistance to widely used anti-estrogen drugs
Researchers at Georgetown have uncovered a single molecule they say is a major determinant of resistance to anti-estrogen therapy used to treat or prevent breast cancer in high-risk women. The scientists say glucose-regulated protein 78, activated as breast cells undergo stress induced by the agents tamoxifen and fulvestrant, turns off apoptosis, a cell death response, and turns on autophagy.

National Institutes of Health, NIH/National Cancer Institute
Contact: Karen Mallet
km463@georgetown.edu
Georgetown University Medical Center
Public Release: 1-Jul-2012
 Nature
Potential treatment target identified in an animal model of pancreatic cancer
Detailed analysis of genes expressed in circulating tumor cells -- cells that break off from solid tumors and travel through the bloodstream -- has identified a potential treatment target in metastatic pancreatic cancer.

Stand Up to Cancer, Howard Hughes Medical Institute, NIH/National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Pancreatic Cancer Action Network, Warshaw Institute for Pancreatic Cancer Research
Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital
Public Release: 1-Jul-2012
 Nature Materials
Penn researchers improve living tissues with 3-D printed vascular networks made from sugar
New advances in tissue engineering could one day make a replacement liver from a patient's cells, or animal muscle tissue that could be cut into steaks. One problem with making 3-D tissue structures, however, is keeping the interior cells from suffocating.
Now, University of Pennsylvania researchers have developed an innovative solution: they've shown that 3-D printed templates of filament networks can be used to rapidly create vasculature and improve the function of engineered living tissues.

National Institutes of Health, Penn Center for Engineering Cells and Regeneration, American Heart Association, Jon Holden DeHaan Foundation
Contact: Evan Lerner
elerner@upenn.edu
215-573-6604
University of Pennsylvania
Public Release: 1-Jul-2012
 Nature Methods
Scripps Research Institute Scientists Develop Alternative to Gene Therapy
Scientists at the Scripps Research Institute have discovered a surprisingly simple and safe method to disrupt specific genes within cells. The scientists highlighted the medical potential of the new technique by demonstrating its use as a safer alternative to an experimental gene therapy against HIV infection.

National Institutes of Health, Skaggs Institute of Chemical Biology at Scripps Research
Contact: Mika OnoScripps Research Institute scientists develop alternative to gene therapy
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Public Release: 1-Jul-2012
 Nature Neuroscience
Why chronic pain is all in your head
Why do some people with similar injuries end up with chronic pain while others recover and are pain free? The first longitudinal brain imaging study to track participants with a new back injury shows that the more two sections of the brain related to emotional and motivational behavior communicate, the greater likelihood a patient will develop chronic pain. Researchers were able to predict, at the beginning of the study, which participants would go on to develop chronic pain based on the level of brain interaction.

NIH/National Institute of Neurological Disorders and Stroke
Contact: Marla Paul
marla-Paul@northwestern.edu
312-503-8928
Northwestern University
Public Release: 1-Jul-2012
 Nature Biotechnology
An error-eliminating fix overcomes big problem in '3rd-gen' genome sequencing
A team has developed a software package that fixes a serious problem inherent in "3rd-gen" single-molecule genome sequencing: the fact that every fifth or sixth DNA "letter" it generates is incorrect. The high error rate is the flip side of the new method's chief virtue: it generates much longer genome "reads," providing a much more complete picture of genomes.

US Department of Homeland Security, US Department of Energy, National Institutes of Health, National Science Foundation, Howard Hughes Medical Institute
Contact: Peter Tarr
tarr@cshl.edu
917-435-5068
Cold Spring Harbor Laboratory
Public Release: 1-Jul-2012
 Nature
Beyond base pairs: Mapping the functional genome
In a paper published in the July 1, 2012, issue of the journal Nature, researchers at the Ludwig Institute for Cancer Research and the University of California, San Diego School of Medicine open the book further, mapping for the first time a significant portion of the functional sequences of the mouse genome, the most widely used mammalian model organism in biomedical research.

NIH/National Human Genome Research Institute
Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Public Release: 29-Jun-2012
 Molecular Cancer Research
New marker, new target in Ewing's sarcoma
Study published this week in Molecular Cancer Research implicates the protein EYA3 in Ewing's sarcoma chemoresistance. Checking level could help offer accurate prognosis and aid in treatment decisions, and could eventually provide a therapeutic target.

NIH/National Cancer Institute
Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Public Release: 29-Jun-2012
 Gastrointestinal Endoscopy
New study finds low rates of biopsy contribute to celiac disease underdiagnosis in US
Under-performance of small bowel biopsy during endoscopy may be a major reason that celiac disease remains underdiagnosed in the United States, according to a new study published online recently in Gastrointestinal Endoscopy. Investigators at the Celiac Disease Center at Columbia University Medical Center (CUMC) found that the rate of small bowel biopsy is low in this country.

National Institutes of Health
Contact: Karin Eskenazi
ket2116@columbia.edu
212-342-0508
Columbia University Medical Center
Public Release: 29-Jun-2012
 Neuroscience
Easter Island drug raises cognition throughout life span
Rapamycin, a compound first isolated from soil on Easter Island, enhanced learning and memory in a study of young, middle-aged and older mice. The findings are from the School of Medicine and Barshop Institute at The University of Texas Health Science Center San Antonio.

National Institutes of Health, Alzheimer's Association, Ellison Medical Foundation
Contact: Will Sansom
sansom@uthscsa.edu
210-567-2579
University of Texas Health Science Center at San Antonio
Public Release: 29-Jun-2012
 Psychological Science
University of Pittsburgh study reveals moderate doses of alcohol increase social bonding in groups
A new study led by University of Pittsburgh researchers reveals that moderate amounts of alcohol--consumed in a social setting--can enhance positive emotions and social bonding and relieve negative emotions among those drinking.

NIH/National Institute on Alcohol Abuse and Alcoholism
Contact: Anna Mikulak
amikulak@psychologicalscience.org
202-293-9300
Association for Psychological Science
Public Release: 29-Jun-2012
AFAR's MSTAR program addresses shortage of geriatric medicine physicians
One hundred forty-seven students from some of the nation's top medical schools are entering a unique program addressing the shortage of physicians specially trained to care for America's older adults -- a shortage that is expected to get far worse in coming years. The American Federation for Aging Research's Medical Student Training in Aging Research Program, funded through a private-public partnership, addresses this issue by exposing future physicians to geriatric medicine experiences early in their careers.

MetLife Foundation, John A. Hartford Foundation, NIH/National Institute on Aging
Contact: Ashby Andrews
ashby@afar.org
212-703-9977
American Federation for Aging Research
Public Release: 29-Jun-2012
 Proceedings of the National Academy of Sciences
Acoustic tweezers capture tiny creatures with ultrasound
A device about the size of a dime can manipulate living materials such as blood cells and entire small organisms, using sound waves, according to a team of bioengineers and biochemists from Penn State.

National Science Foundation, National Institutes of Health
Contact: Walt Mills
wem12@psu.edu
814-865-0285
Penn State
Public Release: 28-Jun-2012
 Cancer Research
Study identifies pathway to enhance usefulness of EGFR inhibitors in lung cancer treatment
A study published today in Cancer Research details the role of the Wnt signaling pathway in aiding lung cancer cell survival after EGFR inhibition therapy. The rational combination of EGFR inhibitors with Wnt inhibitors moves to the preclinical pipeline.

NIH/National Cancer Institute, National Institutes of Health
Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Denver
Public Release: 28-Jun-2012
UMass Amherst biochemists developing tools to stop plague and other bacterial threats
Many of these pathogens are listed as bioterrorism agents by the US Centers for Disease Control and Prevention. It could become very important in the future to be able to mount an entirely new defense against their extremely effective methods of infecting populations with virulent bacterial diseases.

NIH/National Institute of General Medical Sciences, UMass Amherst
Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst
Public Release: 28-Jun-2012
 Behavior Therapy
Research at UH finds cognitive-behavioral therapy effective in combatting anxiety disorders
Whether it is a phobia like a fear of flying, public speaking or spiders, or a diagnosis such as obsessive compulsive disorder, new research finds patients suffering from anxiety disorders showed the most improvement when treated with cognitive-behavioral therapy (CBT) in conjunction with a "transdiagnostic" approach -- a model that allows therapists to apply one set of principles across anxiety disorders.

NIH/National Institute of Mental Health
Contact: Melissa Carroll
mcarroll@uh.edu
713-743-8153
University of Houston
Public Release: 28-Jun-2012
Study offers new insights into the effects of stress on pregnancy
Expectant mothers who dealt with the strain of a hurricane or major tropical storm passing nearby during their pregnancy had children who were at elevated risk for abnormal health conditions at birth, according to a study led by a Princeton University researcher that offers new insights into the effects of stress on pregnancy.

NIH/National Institute of Child Health and Human Development
Contact: Michael Hotchkiss
mh14@princeton.edu
609-258-9522
Princeton University
Public Release: 28-Jun-2012
 Journal of Biological Chemistry
Forty's a crowd
Molecular geneticists call big boss proteins that switch on broad developmental or metabolic programs "master regulators," as in master regulators of muscle development or fat metabolism. One such factor, the Activating Transcription Factor 6α (ATF6α) protein, takes charge following a cellular crisis known as endoplasmic reticulum (ER) stress, which is triggered by the accumulation of misfolded and aggregated proteins.

Stowers Institute for Medical Research, NIH/National Institute of General Medical Science, Helen Nelson Medical Research Fund
Contact: Kristin Kessler
krk@stowers.org
816-926-4139
Stowers Institute for Medical Research
Public Release: 28-Jun-2012
 Ophthalmology
Good news for aging eyes
Today's senior citizens are reporting fewer visual impairment problems than their counterparts from a generation ago, according to a new Northwestern Medicine study. Improved techniques for cataract surgery and a reduction in the prevalence of macular degeneration may be the driving forces behind this change, the researchers said.

Research to Prevent Blindness, NIH/National Institute on Disability and Rehabilitation Research, US Department of Education
Contact: Erin White
ewhite@northwestern.edu
847-491-4888
Northwestern University
Public Release: 28-Jun-2012
 Science
Gene discovery helps explain how flu can cause severe infections
Scientists have discovered a new gene in the influenza virus that helps the virus control the body's response to infection.
Although this control is exerted by the virus, surprisingly it reduces the impact of the infection.

Biotechnology and Biological Sciences Research Council, Medical Research Council, National Institutes of Health, Science Foundation Ireland, Wellcome Trust
Contact: Tara Womersley
tara.womersley@ed.ac.uk
44-131-650-9836
University of Edinburgh
Public Release: 28-Jun-2012
 Cell Stem Cell
Turning skin cells into brain cells
Johns Hopkins researchers, working with an international consortium, say they have generated stem cells from skin cells from a person with a severe, early-onset form of Huntington's disease, and turned them into neurons that degenerate just like those affected by the fatal inherited disorder.

NIH/National Institute of Neurological Disorders and Stroke, CHDI Foundation Inc.
Contact: Stephanie Desmon
sdesmon1@jhmi.edu
410-955-8665
Johns Hopkins Medicine
Public Release: 28-Jun-2012

ENDO 2012: The 94th Annual Meeting & EXPO
LA BioMed investigator Dr. Christina Wang spearheads study on new male contraceptive gel
Christina Wang, M.D., lead investigator at Los Angeles Biomedical Research Institute -- one of the leading biomedical research institutes in the country -- recently completed a study utilizing a new contraceptive gel that has the potential to be developed as a user controlled chemical birth control agent for males.

NIH/National Institute of Child Health and Human Development
Contact: Diana Soltesz
diana@dsmmedia.com
818-592-6747
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Public Release: 28-Jun-2012
 Cell Stem Cell
Cedars-Sinai researchers, with stem cells and global colleagues, develop Huntington’s research tool
Cedars-Sinai scientists have joined with expert colleagues around the globe in using stem cells to develop a laboratory model for Huntington's disease, allowing researchers for the first time to test directly on human cells potential treatments for this fatal, inherited disorder.

National Institutes of Health, CHDI Foundation, Inc., CIRM
Contact: Nicole White
nicole.white@cshs.org
310-423-5215
Cedars-Sinai Medical Center
Public Release: 28-Jun-2012
 Diabetes Care
UT Southwestern study shows treating diabetes early, intensively is best strategy
Intensive early treatment of type 2 diabetes slows down progression of the disease by preserving the body's insulin-producing capacity, a UT Southwestern study has shown.

National Institutes of Health, Novo Nordisk Inc.
Contact: Debbie Bolles
debbie.bolles@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Public Release: 28-Jun-2012
 Chemistry & Biology
Studying fish to learn about fat
In mammals, most lipids (such as fatty acids and cholesterol) are absorbed into the body via the small intestine. The complexity of the cells and fluids that inhabit this organ make it very difficult to study in a laboratory setting. New research from Carnegie's Steven Farber, James Walters and Jennifer Anderson reveals a technique that allows scientists to watch lipid metabolism in live zebrafish. This method enabled them to describe new aspects of lipid absorption that could have broad applications for human health.

National Institutes of Health, American Heart Association, G. Harold and Leila Y. Mathers Charitable Foundation, Carnegie Institution for Science Endowment
Contact: Steve Farber
farber@ciwemb.edu
410-246-3072
Carnegie Institution

Showing releases 2976-3000 out of 3325. << < 115 | 116 | 117 | 118 | 119 | 120 | 121 | 122 | 123 | 124 > >>

|